BioCentury
ARTICLE | Finance

Cancer immunotherapy mentor

February 8, 2010 8:00 AM UTC

Mentor Capital Inc. (Pink:MNTR) has collected $126.3 million in commitments to invest in its Cancer Immunotherapy Index, which was launched in July 2009.

The company has received the first seed tranche of $1.2 million from 1,400 investors and will receive the rest in three more tranches over the next two years, said CEO Chet Billingsley...